Search results
Results from the WOW.Com Content Network
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. [1] India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
27 October - 2024 Mumbai stampede:A stampede occurs at the Bandra Terminus railway station in Mumbai, injuring nine people, two of them critically. [177] [178] 28 October – The first private military aircraft manufacturing facility in India is inaugurated in Vadodara as part of a joint venture between Airbus and Tata Advanced Systems. [179]
Emcure Pharmaceuticals was established in 1981 by Satish Mehta, who began the company with a bank loan of ₹ 3 lakh (about US$35,000 then) after graduating from IIM-A. [9] In the 1990s, the company transitioned from being a contract manufacturing organization to a producer of generic drugs .
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. ... This page was last edited on 5 March 2024, at 20:45 (UTC).
The UCPMP is an extension of the Uniform Code for Pharmaceuticals Marketing Practices 2015 (UCPMP 2015), which took effect on 1 January 2015.Although there were long-standing expectations that the 2015 Code would be legally enforced, it remained a voluntary guideline for pharmaceutical companies to follow in their marketing practices.
On 4 March 2024, Cadila Pharmaceuticals announced the launch of Cadiflu Tetra, a quadrivalent influenza vaccine approved for use in adults and children by the Drugs Controller General of India (DCGI), using proprietary technology with nano-sized particles to mimic the virus's external structure without containing its genetic material.
Lupin's businesses encompass the entire pharmaceutical value chain, ranging from branded and generic formulations, APIs, advanced drug delivery systems to biotechnology. . The company's drugs reach 70 countries [22] with a footprint that covers advanced markets such as USA, Europe, Japan, [23] Australia as well as emerging markets including India, the Philippines and South Africa to name a